Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McCune

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 15, 2014
Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetilHong Li, Donald E Mager, Brenda M Sandmaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in OncologySharon P Shriver, Devon Adams, Brittany Avin McKelvey, et al.
Bone Marrow Transplantation|May 10, 2011
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationL Johnston, M Florek, R Armstrong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2018
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended ApproachEmily J Johnson, Vanessa González-Peréz, Dan-Dan Tian, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 7, 2011
Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivoBrianne S Raccor, Adam J Claessens, Jean C Dinh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2014
Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantationMeagan J Bemer, Linda J Risler, Brian R Phillips, et al.
Cancer Investigation|October 6, 2005
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancerHeidi H Gillenwater, Jeannine S McCune, Celeste Lindley, et al.
Nature Biomedical Engineering|August 15, 2022
A wearable electrochemical biosensor for the monitoring of metabolites and nutrientsMinqiang Wang, Yiran Yang, Jihong Min, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 15, 2014
Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetilHong Li, Donald E Mager, Brenda M Sandmaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in OncologySharon P Shriver, Devon Adams, Brittany Avin McKelvey, et al.
Bone Marrow Transplantation|May 10, 2011
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationL Johnston, M Florek, R Armstrong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2018
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended ApproachEmily J Johnson, Vanessa González-Peréz, Dan-Dan Tian, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 7, 2011
Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivoBrianne S Raccor, Adam J Claessens, Jean C Dinh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2014
Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantationMeagan J Bemer, Linda J Risler, Brian R Phillips, et al.
Cancer Investigation|October 6, 2005
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancerHeidi H Gillenwater, Jeannine S McCune, Celeste Lindley, et al.
Nature Biomedical Engineering|August 15, 2022
A wearable electrochemical biosensor for the monitoring of metabolites and nutrientsMinqiang Wang, Yiran Yang, Jihong Min, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Pageof 18